BRCA2 and breast cancer: We may thus have a smaller fraction of individuals at the end-tail of the PRS distribution (PRS >99th percentile tested in this study) with an odds ratio equivalent to BRCA1 (OR = 10.57) and BRCA2 (OR = 5.85) mutations in the field of breast cancer.34